首页> 外文期刊>Journal of Clinical Pathology >Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children.
【24h】

Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children.

机译:肾小球系膜纤维蛋白原沉积在儿童新月形过敏性肾炎-Schonlein肾炎发病中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: To clarify the role of mesangial fibrinogen deposition in crescentic Henoch-Schonlein nephritis (HSN). METHODS: A retrospective analysis of 21 children with HSN treated with immunosuppressants. Serial renal biopsies were performed before and after treatment. They were divided into two groups according to the immunofluorescent course of fibrinogen deposition: group I (n = 9), no or decreased deposition; group II (n = 12), persistent or increased deposition. RESULTS: There were no differences between the two groups in renal manifestations or laboratory and histological findings at presentation. However, the activity index after immunosuppressive treatment was significantly decreased in group I (mean, 7.9 (SEM, 0.7) v 2.9 (0.4); p = 0.008) and unchanged in group II (mean, 6.8 (SEM, 0.3) v 6.0 (2.1)). The chronicity index was unchanged in group I, but increased in group II (mean, 0.8 (SEM, 0.3) v 1.8 (0.3); p = 0.02). Univariate analysis revealed that the only factor significantly related to persistent or increased fibrinogen deposition was age more than 9 years (p = 0.03). Furthermore, the intensity of fibrinogen deposition at the second biopsy correlated positively with the age at onset (R2= 0.306; p = 0.009) and changes in the percentage of crescents (post-treatment crescents (%) minus pretreatment crescents (%)) correlated positively with the intensity of fibrinogen deposition at the second biopsy (R2= 0.193; p = 0.046). CONCLUSIONS: This study indicates that fibrinogen deposition has an important role to play in renal injury of crescentic HSN and reflects persistent severe histological activity.
机译:目的:阐明肾小球系膜纤维蛋白原沉积在新月型过敏性肾炎-舍恩莱因肾炎(HSN)中的作用。方法:回顾性分析21例接受免疫抑制剂治疗的HSN儿童。在治疗前后进行了连续的肾脏活检。根据纤维蛋白原沉积的免疫荧光过程将它们分为两组:第一组(n = 9),无或减少沉积;第二组(n = 9)。第二组(n = 12),持续性或沉积增加。结果:两组在肾脏表现或实验室及组织学表现方面无差异。但是,免疫抑制治疗后的活性指数在I组中显着降低(平均值7.9(SEM,0.7)v 2.9(0.4); p = 0.008),而在II组中则没有变化(平均值6.8(SEM,0.3)v 6.0( 2.1))。慢性指数在第一组没有变化,但在第二组有所增加(平均值为0.8(SEM,0.3)对1.8(0.3); p = 0.02)。单因素分析显示,与持续或增加纤维蛋白原沉积显着相关的唯一因素是年龄超过9岁(p = 0.03)。此外,第二次活检时纤维蛋白原沉积的强度与发病年龄呈正相关(R2 = 0.306; p = 0.009),而新月体百分比的变化(治疗后新月体(%)减去治疗前新月体(%))相关。与第二次活检时纤维蛋白原沉积的强度呈正相关(R2 = 0.193; p = 0.046)。结论:本研究表明纤维蛋白原沉积在新月型HSN的肾损伤中起重要作用,并反映了持续的严重组织学活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号